Opko Health, Inc.
Clinical trials sponsored by Opko Health, Inc., explained in plain language.
-
New MASH drug OPK-88006 enters early human testing
Disease control Not yet recruitingThis early-stage study tests a new drug called OPK-88006 in 30 people, first in healthy volunteers and then in those with MASH (a serious liver condition). The goal is to check safety, how the drug moves through the body, and early signs of liver improvement. Results will help de…
Phase: PHASE1, PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for kids with kidney disease: experimental vitamin d pill enters trial
Disease control Not yet recruitingThis study tests an extended-release vitamin D capsule (CTAP101) in 40 children aged 8 to 17 with stage 3 or 4 chronic kidney disease, secondary hyperparathyroidism, and low vitamin D. Participants take one capsule daily at bedtime for 8 weeks. The goal is to see how the body pro…
Phase: PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC